HF
CYAD

HRT Financial’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

HRT Financial’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33,288
Closed -$57K – 3759
2022
Q2 		$57K Sell
33,288
-3,512
-10% -$7.03K ﹤0.01% 2503
2022
Q1 		$88K Sell
36,800
-1,305
-3% -$3.99K ﹤0.01% 2684
2021
Q4 		$139K Buy
+38,105
New +$160K ﹤0.01% 2671

Other funds holding CYAD

FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HRT Financial's CYAD Position: Q3 2022 in Review

HRT Financial sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q3 2022, closing a stake of 33,288 shares — an estimated $57K sold.

HRT Financial first reported a position in CYAD in Q4 2021 and held it in 3 quarters. The position peaked at $139K in Q4 2021. 8 funds tracked by Wall St. Rank hold CYAD as of Q3 2022.

  • HRT Financial reported no remaining Celyad Oncology SA American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 33,288 Celyad Oncology SA American Depositary Shares shares in Q3 2022, an estimated $57K.
  • HRT Financial first reported a position in Celyad Oncology SA American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • HRT Financial's Celyad Oncology SA American Depositary Shares position peaked at $139K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.